Search result for 'drl'

Dr Reddy's Laboratories has received a show-cause notice from the income tax authority demanding over Rs 2,395 crore related to the merger of Dr Reddy's Holding Ltd.

Dr Reddy's Laboratories received seven observations from the USFDA following an inspection of its Bollaram facility. The company will address the observations within the stipulated timeline.

Dr Reddy's Laboratories reports a 9.35% decline in Q2 net profit to Rs 1,341.5 crore, while revenue increased 16.51% to Rs 8,016.2 crore. Read more.

Dr Reddy's Laboratories reported a 9% decline in Q2 profit to Rs 1,342 crore, while revenue rose 17% to Rs 8,016 crore. The company attributed the growth to strong performance across its businesses.

Dr Reddy's Laboratories has signed a licensing agreement with Ingenus Pharmaceuticals to commercialize Cyclophosphamide injection for cancer treatment in the US.

Kinetic Green launches its new electric scooter ZULU, aiming to dominate the two and three-wheeler market. Featuring a battery subscription model and advanced features, the ZULU offers...